Limited Partners
|
Contact Us
About Us
Portfolio
Our Team
News & Events
For Entrepreneurs
Portfolio Company News
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
Aurora News
Newsletters
Events
Speaking Engagements
Portfolio Company News, 2013
July 1
Argos Therapeutics Announces Plans for HIV Eradication Study
June 28
Digitalsmiths Expands Senior Management Team and Board of Directors
June 13
Leading HIV Researchers and Argos Therapeutics Highlight Importance of Immunotherapy in HIV Eradication Efforts
June 10
Argos Therapeutics Announces US and Global Expansion for Ongoing Pivotal Phase 3 ADAPT Study for Personalized Immunotherapy
May 29
Health Diagnostic Laboratory, Inc.'s new Diabetes Prevention & Management Panel incorporates discovery from Metabolon researchers
May 8
Argos Confirms Improved RNA Amplification Protocol Enhances Quality of Antigen-Specific Immune Response
January 14
Argos Therapeutics Enrolls Initial Patients in Pivotal Phase 3 ADAPT Study
About Us
Portfolio
Our Team
News & Events
For Entrepreneurs
©2002–2013 The Aurora Funds, Inc.